Health Canada regulates the approval of generic pharmaceuticals, allowing market entry following patent expiration.
Steady: 1 in the last 7 days
Updated thursday
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Health Canada regulates the approval of generic pharmaceuticals, allowing market entry following patent expiration.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Sandoz applied to Health Canada for approval of generic semaglutide, capitalizing on the Ozempic patent expiration.Sub-event
- Health Canada approved TLANDO capsules, allowing Verity Pharma to plan commercialization in Canada.Sub-event
Health Canada oversees generic drug manufacturing and approval following patent expiration.1 source
Successful NOC obtained for Apotex's generic pharmaceuticals from Health Canada.1 source
Keep exploring
The entities involved
-
Health Canada
Department of the Canadian Government that oversees public health
-
Apotex
Canadian private pharmaceutical company
Nothing else this week.
-
Novo Nordisk
Danish pharmaceutical company